Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure-activity relationship modeling of peptides containing 4-10 amino acid residues

被引:147
作者
Wu, Jianping [1 ]
Aluko, Rotimi E.
Nakai, Shuryo
机构
[1] Univ Manitoba, Dept Human Nutrit Sci, Winnipeg, MB R3T 2N2, Canada
[2] Univ British Columbia, Fac Agr Sci, Vancouver, BC V6T 1Z4, Canada
来源
QSAR & COMBINATORIAL SCIENCE | 2006年 / 25卷 / 10期
关键词
angiotensin converting enzyme; bioactive peptides; QSAR; partial least squares regression;
D O I
10.1002/qsar.200630005
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Models for angiotensin converting enzyme (ACE) inhibitory peptides with varied lengths are proposed based on results from partial least square regression analysis of the potency of known peptides. Modeling was performed using partial least square regression with inhibitory activity of peptides as the dependent variable (Y) and the physicochemical properties of amino acids as the predictor X matrix. Variable importance in the projection (VIP) analysis of individual amino acid residues at each position revealed that the C-terminal tetrapeptide residues of long-chain peptides were more important to their ACE-inhibitory activity than the C-terminal tripeptide residues. The most likely preferred amino acid residues starting from C-terminus are tyrosine and cysteine for the first position, histidine, tryptophan and methionine for the second position with isoleucine, leucine, valine and methionine for the third position, and tryptophan for the fourth position. We concluded that the reported structural requirements of ACE-inhibitory peptides provide useful information that can be used for the development of more efficacious ACE-inhibitory peptides.
引用
收藏
页码:873 / 880
页数:8
相关论文
共 29 条
[1]   ACE revisited: A new target for structure-based drug design [J].
Acharya, KR ;
Sturrock, ED ;
Riordan, JF ;
Ehlers, MRW .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (11) :891-902
[2]   Preprocessing peptide sequences for multivariate sequence-property analysis [J].
Andersson, PM ;
Sjostrom, M ;
Lundstedt, T .
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 1998, 42 (1-2) :41-50
[3]   Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme [J].
Araujo, MC ;
Melo, RL ;
Cesari, MH ;
Juliano, MA ;
Juliano, L ;
Carmona, AK .
BIOCHEMISTRY, 2000, 39 (29) :8519-8525
[4]   ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS DERIVED FROM FOOD PROTEINS [J].
ARIYOSHI, Y .
TRENDS IN FOOD SCIENCE & TECHNOLOGY, 1993, 4 (05) :139-144
[5]  
CHEUNG HS, 1980, J BIOL CHEM, V255, P401
[6]  
CHI CW, 1985, PEPTIDES, V6, P339
[7]   INHIBITION OF ANGIOTENSIN-CONVERTING ENZYME BY ANALOGS OF PEPTIDES FROM BOTHROPS-JARARACA VENOM [J].
CUSHMAN, DW ;
PLUSCEC, J ;
WILLIAMS, NJ ;
WEAVER, ER ;
SABO, EF ;
KOCY, O ;
CHEUNG, HS ;
ONDETTI, MA .
EXPERIENTIA, 1973, 29 (08) :1032-1035
[8]   DESIGN OF POTENT COMPETITIVE INHIBITORS OF ANGIOTENSIN-CONVERTING ENZYME - CARBOXYALKANOYL AND MERCAPTOALKANOYL AMINO-ACIDS [J].
CUSHMAN, DW ;
CHEUNG, HS ;
SABO, EF ;
ONDETTI, MA .
BIOCHEMISTRY, 1977, 16 (25) :5484-5491
[9]   Design of angiotensin converting enzyme inhibitors [J].
Cushman, DW ;
Ondetti, MA .
NATURE MEDICINE, 1999, 5 (10) :1110-1112
[10]  
Dunn III WJ, 1995, CHEMOMETRIC METHODS, P179